miR‐200b‐3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer

Background Numerous abnormally expressed miRs have been reported involved in oxaliplatin (L‐OHP) resistance of colorectal cancer (CRC). The present study aimed to investigate whether miR‐200b‐3p could regulate L‐OHP resistance via targeting TUBB3 in CRC cells. Methods L‐OHP resistant HT29 and HCT116...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The journal of gene medicine 2020-07, Vol.22 (7), p.e3178-n/a
Hauptverfasser:	Wu, Yu‐Zhu, Lin, Hong‐Yue, Zhang, Yin, Chen, Wen‐Fa
Format:	Artikel
Sprache:	eng
Schlagworte:	Annexin V Apoptosis Bioinformatics Cholecystokinin Colorectal cancer Colorectal carcinoma Gene therapy miR‐200b‐3p Oxaliplatin Protein expression resistance TUBB3 Tubulin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!